1. Home
  2. SLB vs ZTS Comparison

SLB vs ZTS Comparison

Compare SLB & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Schlumberger N.V.

SLB

Schlumberger N.V.

HOLD

Current Price

$46.70

Market Cap

53.5B

Sector

Energy

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$125.07

Market Cap

53.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLB
ZTS
Founded
1926
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.5B
53.9B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
SLB
ZTS
Price
$46.70
$125.07
Analyst Decision
Strong Buy
Buy
Analyst Count
17
11
Target Price
$49.66
$174.60
AVG Volume (30 Days)
16.7M
4.8M
Earning Date
01-23-2026
02-12-2026
Dividend Yield
2.44%
1.70%
EPS Growth
N/A
11.64
EPS
2.57
5.94
Revenue
$35,247,000,000.00
$9,397,000,000.00
Revenue This Year
N/A
$3.04
Revenue Next Year
$4.34
$4.96
P/E Ratio
$18.18
$21.00
Revenue Growth
N/A
2.68
52 Week Low
$31.11
$115.25
52 Week High
$47.73
$177.40

Technical Indicators

Market Signals
Indicator
SLB
ZTS
Relative Strength Index (RSI) 75.83 49.11
Support Level $46.08 $123.32
Resistance Level $47.73 $126.50
Average True Range (ATR) 1.24 2.69
MACD 0.52 -0.10
Stochastic Oscillator 89.84 21.94

Price Performance

Historical Comparison
SLB
ZTS

About SLB Schlumberger N.V.

SLB is the world's premier oilfield-services company as measured by market share. While the industry is largely fragmented, SLB holds the first or second competitive position in many of the differentiated oligopolies in which it operates. Also known as Schlumberger, the company was founded in 1926 by two brothers bearing the same last name. Today, it's most known as a global industry leader in innovation, while it focuses its strategy on its three growth engines: core, digital, and new energy businesses. Over three-fourths of its revenue base is tied to international markets, while the company boasts roughly $3 billion in digital-related revenue.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: